Geospatial immune variability illuminates differential evolution of lung adenocarcinoma

Journal: Nature Medicine

Published: 2020-05-27

DOI: 10.1038/s41591-020-0900-x

Affiliations: 56

Authors: 278

Go to article
Institutions Share
UCL Cancer Institute, United Kingdom (UK) 0.14
University College London Hospitals NHS Foundation Trust (UCLH), United Kingdom (UK) 0.10
The Francis Crick Institute, United Kingdom (UK) 0.08
Wythenshawe Hospital, MFT, United Kingdom (UK) 0.07
Royal Brompton and Harefield NHS Foundation Trust, United Kingdom (UK) 0.07
Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom (UK) 0.06
University Hospitals Birmingham NHS Foundation Trust (UHB), United Kingdom (UK) 0.04
Aberdeen Royal Infirmary, NHS Grampian, United Kingdom (UK) 0.03
Cancer Research UK and UCL Cancer Trials Centre (UCL CTC), United Kingdom (UK) 0.03
Leicester Cancer Research Centre (LCRC), United Kingdom (UK) 0.03
University Hospitals of Leicester NHS Trust (UHL), United Kingdom (UK) 0.03
CRUK Lung Cancer Centre of Excellence, United Kingdom (UK) 0.03
Manchester Cancer Research Centre (MCRC), United Kingdom (UK) 0.02
Golden Jubilee National Hospital, NHSGGC, United Kingdom (UK) 0.02
Barts Health NHS Trust, United Kingdom (UK) 0.02
Cardiff & Vale University Health Board, United Kingdom (UK) 0.02
University Hospital Southampton NHS Foundation Trust, United Kingdom (UK) 0.02
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.02
The Christie NHS Foundation Trust, United Kingdom (UK) 0.01
UCL Faculty of Medical Sciences, United Kingdom (UK) 0.01
Cancer Research UK Manchester Institute, UoM, United Kingdom (UK) 0.01
Princess Alexandra Hospital NHS Trust, United Kingdom (UK) 0.01
NHS Greater Glasgow and Clyde (NHSGGC), United Kingdom (UK) 0.01
Liverpool Heart and Chest Hospital, United Kingdom (UK) 0.01
University of Leicester, United Kingdom (UK) 0.01
The University of Manchester (UoM), United Kingdom (UK) 0.01
Department of Physics of Complex Systems, ELTE, Hungary 0.01
NIHR Leicester Respiratory Biomedical Research Unit (BRU), United Kingdom (UK) 0.01
The Whittington Hospital, Whittington Health NHS, United Kingdom (UK) 0.01
Independent Cancer Patients' Voice (ICPV), United Kingdom (UK) 0.01
ICR Centre for Evolution and Cancer, United Kingdom (UK) 0.01
Barnet and Chase Farm Hospitals NHS Trust, United Kingdom (UK) 0.01
Ashford and St Peter's Hospitals NHS Foundation Trust, United Kingdom (UK) 0.01
ICR Division of Molecular Pathology, United Kingdom (UK) 0.01
MRC Toxicology Unit, University of Cambridge, United Kingdom (UK) 0.01
Research Division, Peter Mac, Australia 0
The University of Melbourne (UniMelb), Australia 0
University College Hospital (UCH), United Kingdom (UK) 0
The Royal Marsden Hospital - London, The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0
Danish Cancer Society Research Center (DCRC), Denmark 0
Velindre Cancer Centre, Velindre NHS Trust, United Kingdom (UK) 0
Royal Liverpool University Hospital, The Royal Liverpool and Broadgreen University Hospitals NHS Trust, United Kingdom (UK) 0
Glenfield Hospital, United Kingdom (UK) 0
GZA Hospitals, Belgium 0
Berlin Institute for Medical Systems Biology (BIMSB), MDC, Germany 0
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0
DKTK Partner Site Berlin, Germany 0
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0
Department of Radiology, NKI, Netherlands 0
Brigham and Women's Hospital (BWH), United States of America (USA) 0
Division of Infection, Immunity and Respiratory Medicine (IIRM), UoM, United Kingdom (UK) 0

Return